Smartfish´s medical nutrition product Remune® to be used in international research program for lung diseases
The Dutch consortium “Precision Medicine for more Oxygen” (P4O2) announces the official start of a research program to fundamentally improve the early detection, prevention, and treatment of lung disease. In the study, RemuneTM from Smartfish AS has been chosen as the targeted nutritional medical product in the research arm that investigates the impact of nutritional support.
Swimming legend Emma Igelström is serious about recovery for young athletes
Smartfish Sport is happy to announce its latest collaboration with swimming legend Emma Igelström. Emma is a former Swedish breaststroke swimmer and five times World Champion.
LIPIDS publishes PREPARE study on intervention with Smartfish´ Marine Omega-3 Fatty Acids emulsion demonstrating effect on the follicular fluid for couples awaiting IVF
The University of Southampton has published another study from the PREPARE (PREconception dietary suPplements in Assisted REproduction) TRIAL investigating the effects of a six-week dietary intervention with Smartfish´ marine omega-3 fatty acids on fertility. The findings demonstrate an altered fatty acid composition of follicular fluid following the 6-week intervention (1).
Press release: Smartfish partners with the international Public-Private Consortium P4O2 (Precision Medicine for More Oxygen) investigating risk factors for developing lung damage and chronic complaints after COVID-19
Many patients who have had COVID-19 continue to have health complaints for a long period of time. A team of researchers, private parties and patient representatives will investigate how these complaints develop and which factors can predict them in future patients. The project is co-funded by the PPP Allowance made available by Top Sector Life Sciences & Health (Health~Holland).
First patient recruited in research study investigating the effects of Remune in combination with exercise in cancer patients
Smartfish AS announces today the initiation of a research study at University of Rochester to assess the impact of Remune in combination with exercise on physical function and cachexia-related symptoms in cancer patients. Remune has previously shown to be beneficial in the nutritional management of cancer. The study will include a total of 45 patients.
In-depth analysis of clinical trial results shows that Smartfish’s Remune can improve physical performance in pre-cachectic lung cancer patients
Positive outcomes following an in-depth analysis of data from a previously conducted clinical trial of Remune, an oral targeted medical nutrition supplement, in cancer patients. Results from an in-depth analysis was published today in a Letter to the Editor of Nutrition and Cancer and indicates improved physical function in pre-cachectic patients following Remune nutrition intervention.
New study reports positive results for Smartfish product in patients with declining cognitive function
A new study published today presents positive results from a 6-year-research project at University of California, Los Angeles, where a drink-based nutritional product from Smartfish was used as an add-on to pharmacological treatment in patients with declining cognitive function. The results further strengthen evidence that Smartfish’s high quality nutritional products can enhance clinical outcome.
Smartfish lanserar sin produktportfölj inom consumer health i Asien genom ett nytt strategiskt samarbete med Jacobson Pharma
Smartfish AS påbörjar nu en lansering av sina produkter inom consumer health och sportnutrition på den asiatiska marknaden. Lanseringen sker inom ramen för ett nytt strategiskt samarbete med Jacobson Pharma. Som ett led i samarbetet har Jacobson Pharma nyligen investerat 40 miljoner NOK i Smartfish genom en aktieemission, ett tydligt kvitto på Jacobson Pharmas långsiktiga engagemang i Smartfish.
Smartfish starter utrulling av forbrukerhelseprodukter i Asia gjennom et nytt strategisk partnerskap med Jacobson Pharma
Smartfish AS setter i gang en utrulling av sine forbrukerhelseprodukter til nye markeder i Asia gjennom et nytt strategisk partnerskap med Jacobson Pharma Group. Jacobson Pharma Group investerte nylig 40 millioner kroner i Smartfish gjennom en emisjon, et tydelig tegn på selskapets tro på partnerskapet med Smartfish.
Smartfish initiates Asian rollout of its consumer health products through a new strategic partnership with Jacobson Pharma
Smartfish AS initiates a rollout of its consumer health nutritional products into new markets in Asia through a new strategic partnership with Jacobson Pharma Group. As a strong sign of commitment to the new partnership, Jacobson Pharma Group recently invested NOK 40 million in Smartfish through a share issue.
Smartfish initiates global collaboration with B. Braun, securing forceful launch of its medical nutrition product Remune
Smartfish AS has initiated a strategic collaboration with the global healthcare company B. Braun to secure a forceful global launch of its medical nutrition product Remune. B. Braun will launch Remune in close to 20 countries during 2019 and 2020, followed by several other markets in Europe, Asia and South America.
Smartfish innleder samarbeid med B. Braun for global lansering av sitt medisinske ernæringsprodukt Remune
Smartfish AS har innledet et strategisk samarbeid med det globale medisinske foretaket B. Braun for å sikre en omfattendeglobal lansering av det medisinske ernæringsproduktet Remune. B. Braun vil lansere Remune i nærmere 20 land i løpet av 2019 og 2020, etterfulgt av flere andre markeder verden over.